samedan logo
 
 
 
spacer
home > ebr > summer 2019 > the adc jigsaw
PUBLICATIONS
European Biopharmaceutical Review

The ADC Jigsaw

The decades-old war on cancer has yet to be won. While progress has been significant in many indications, mortality rates for some of the most difficult to treat solid tumour types have not improved substantially since the 1970s. For oesophagus and lung cancer, 10-year survival statistics have shown an increase of less than 10%, and pancreatic cancer has shown no improvement at all (1). Furthermore, even in cancers such as melanoma, breast, and uterine where survival rates have improved, more efficacious treatments with fewer debilitating side effects are needed.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Jenny Thirlway leads Iksuda’s ADC programmes, including the preclinical demonstration of Iksuda’s proprietary PermaLink® conjugation chemistry, the exemplification of novel toxin platforms, and the evaluation of partnered antibodies/ alternative scaffolds, focused on the development of a proofof- concept stage ADC portfolio. Jenny has a post-doctoral background in biochemistry and significant experience in the development of biologics, including antibody-based therapeutics and biosimilars.
spacer
Dr Jenny Thirlway
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IBM Research and Arctoris Accelerate Closed Loop Drug Discovery with AI and Cloud

Oxford and Zurich – 13 September 2021 – Life Science Newswire – Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. IBM Research has developed RXN for Chemistry, an online platform leveraging state-of-the-art Natural Language Processing (NLP) architectures to automate synthetic chemistry.
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement